299 related articles for article (PubMed ID: 12678739)
1. Drug resistance and apoptosis in cancer treatment: development of new apoptosis-inducing agents active in drug resistant malignancies.
Tolomeo M; Simoni D
Curr Med Chem Anticancer Agents; 2002 May; 2(3):387-401. PubMed ID: 12678739
[TBL] [Abstract][Full Text] [Related]
2. Modulating ROS to overcome multidrug resistance in cancer.
Cui Q; Wang JQ; Assaraf YG; Ren L; Gupta P; Wei L; Ashby CR; Yang DH; Chen ZS
Drug Resist Updat; 2018 Nov; 41():1-25. PubMed ID: 30471641
[TBL] [Abstract][Full Text] [Related]
3. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
Wang YJ; Li Q; Xiao HB; Li YJ; Yang Q; Kan XX; Chen Y; Liu XN; Weng XG; Chen X; Cai WY; Guo Y; Huang HF; Zhu XX
Drug Des Devel Ther; 2015; 9():5301-13. PubMed ID: 26445529
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of multidrug resistance in cancer.
Gillet JP; Gottesman MM
Methods Mol Biol; 2010; 596():47-76. PubMed ID: 19949920
[TBL] [Abstract][Full Text] [Related]
7. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
8. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
9. Gallium phosphinoarylbisthiolato complexes counteract drug resistance of cancer cells.
Fischer-Fodor E; Vălean AM; Virag P; Ilea P; Tatomir C; Imre-Lucaci F; Schrepler MP; Krausz LT; Tudoran LB; Precup CG; Lupan I; Hey-Hawkins E; Silaghi-Dumitrescu L
Metallomics; 2014 Apr; 6(4):833-44. PubMed ID: 24413432
[TBL] [Abstract][Full Text] [Related]
10. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.
Nathwani SM; Butler S; Fayne D; McGovern NN; Sarkadi B; Meegan MJ; Lloyd DG; Campiani G; Lawler M; Williams DC; Zisterer DM
Cancer Chemother Pharmacol; 2010 Aug; 66(3):585-96. PubMed ID: 20020128
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms for tumour resistance to chemotherapy.
Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
[TBL] [Abstract][Full Text] [Related]
12. Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells.
Leoni LM; Hamel E; Genini D; Shih H; Carrera CJ; Cottam HB; Carson DA
J Natl Cancer Inst; 2000 Feb; 92(3):217-24. PubMed ID: 10655438
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
Panzarini E; Dini L
Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance.
Kaufmann SH; Vaux DL
Oncogene; 2003 Oct; 22(47):7414-30. PubMed ID: 14576849
[TBL] [Abstract][Full Text] [Related]
15. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
16. Selective induction of apoptosis: promising therapy in pancreatic cancer.
Liu Z; Li D; Zheng X; Wang E; Wang J
Curr Pharm Des; 2013; 19(12):2259-68. PubMed ID: 23082976
[TBL] [Abstract][Full Text] [Related]
17. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.
Shi Q; Zhang L; Liu M; Zhang X; Zhang X; Xu X; Chen S; Li X; Zhang J
Biomaterials; 2015 Oct; 67():169-82. PubMed ID: 26218743
[TBL] [Abstract][Full Text] [Related]
18. A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance.
Ng CP; Bonavida B
Adv Cancer Res; 2002; 85():145-74. PubMed ID: 12374285
[TBL] [Abstract][Full Text] [Related]
19. Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics.
Wijdeven RH; Pang B; Assaraf YG; Neefjes J
Drug Resist Updat; 2016 Sep; 28():65-81. PubMed ID: 27620955
[TBL] [Abstract][Full Text] [Related]
20. [Apoptosis-reactivating agents for targeted anticancer therapy].
Fil'chenkov AA
Biomed Khim; 2013; 59(2):119-43. PubMed ID: 23789342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
